Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation

OMICS A Journal of Integrative Biology

Volumn 16, Issue 1-2, 2012, Pages 24-36

  Ostano, Paola ^a   Bione, Silvia ^b   Belgiovine, Cristina ^b   Chiodi, Ilaria ^b   Ghimenti, Chiara ^a   Scovassi, A Ivana ^b   Chiorino, Giovanna ^a   Mondello, Chiara ^b  

^a Laboratory of Cancer Genomics   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MICRORNA; MYC PROTEIN; PROTEIN P53;

CARCINOGENESIS; CELL TRANSFORMATION; CONFERENCE PAPER; EPIGENETICS; FIBROBLAST; GENE EXPRESSION; GENE SET ENRICHMENT ANALYSIS; GENETIC DATABASE; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CLUSTER ANALYSIS; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICROARRAY ANALYSIS; MICRORNAS;

EID: 84856939046     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0049     Document Type: Conference Paper

References (57)

1. Alt, E., Yan, Y., Gehmert, S., Song, Y.H., Altman, A., Vykoukal, D., et al. (2011). Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colonyforming potential. Biol Cell 103, 197-208.
2. Belgiovine, C., Frapolli, R., Bonezzi, K., Chiodi, I., Favero, F., Mello-Grand, M., et al. (2010). Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLoS One 5, e14154.
3. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57, 289-300.
4. Borgdorff, V., Lleonart, M.E., Bishop, C.L., Fessart, D., Bergin, A.H., Overhoff, M.G., et al. (2010). Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/ Cip1). Oncogene 29, 2262-2271.
5. Bouhallier, F., Allioli, N., Lavial, F., Chalmel, F., Perrard, M.H., Durand, P., et al. (2010). Role of miR-34c microRNA in the late steps of spermatogenesis. RNA 16, 720-731.
6. Bussing, I., Slack, F.J., and Grosshans, H. (2008). let-7 micro- RNAs in development, stem cells and cancer. Trends Mol Med 14, 400-409.
7. Caballero, O.L., and Chen, Y.T. (2009). Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Sci 100, 2014-2021.
8. Cao, Y., Liu, X., Zhang, W., Deng, X., Zhang, H., Liu, Y., et al. (2009). TGF-beta repression of Id2 induces apoptosis in gut epithelial cells. Oncogene 28, 1089-1098.
9. Chang, T.C., Wentzel, E.A., Kent, O.A., Ramachandran, K., Mullendore, M., Lee, K.H., et al. (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26, 745-752. (Pubitemid 46856245)
10. Chang, T.C., Zeitels, L.R., Hwang, H.W., Chivukula, R.R., Wentzel, E.A., Dews, M., et al. (2009). Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 106, 3384-3389.
11. Chapman, E.J., Kelly, G., and Knowles, M.A. (2008). Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol Cancer Res 6, 1154-1168.
12. Chapman, E.J., and Knowles, M.A. (2009). Necdin: A multi functional protein with potential tumor suppressor role? Mol Carcinog 48, 975-981.
13. Donà , F., Chiodi, I., Belgiovine, C., Raineri, T., Ricotti, R., Mondello, C., et al. (in press). Poly(ADP-ribosylation) and neoplastic transformation: Effect of PARP inhibitors. Curr Pharmaceut Biotechnol.
14. Garzon, R., Calin, G.A., and Croce, C.M. (2009). MicroRNAs in cancer. Annu Rev Med 60, 167-179.
15. Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., et al. (2004). Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5, R80.
16. Han, H.J., Russo, J., Kohwi, Y., and Kohwi-Shigematsu, T. (2008). SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452, 187-193. (Pubitemid 351380252)
17. Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: The next generation. Cell 144, 646-674.
18. Hardwick, J.C., Kodach, L.L., Offerhaus, G.J., and Van den Brink, G.R. (2008). Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer 8, 806-812.
19. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833. (Pubitemid 40839734)
20. He, L., He, X., Lim, L.P., De Stanchina, E., Xuan, Z., Liang, Y., et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. (Pubitemid 47014436)
21. Hermeking, H. (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ 17, 193-199.
22. Hurst, D.R., Edmonds, M.D., and Welch, D.R. (2009). Metastamir: The field of metastasis-regulatory microRNA is spreading. Cancer Res 69, 7495-7498.
23. Inomata, M., Tagawa, H., Guo, Y.M., Kameoka, Y., Takahashi, N., and Sawada, K. (2009). MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113, 396-402.
24. Ito, Y., and Miyazono, K. (2003). RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13, 43-47. (Pubitemid 36143926)
25. Jiang, Q., Feng, M.G., and Mo, Y.Y. (2009). Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 9, 194.
26. Kvolik, S., Jukic, M., Matijevic, M., Marjanovic, K., and Glavas- Obrovac, L. (2010). An overview of coagulation disorders in cancer patients. Surg Oncol 19, e33-46.
27. Lakshman, M., Huang, X., Ananthanarayanan, V., Jovanovic, B., Liu, Y., Craft, C.S., et al. (2011). Endoglin suppresses human prostate cancer metastasis. Clin Exp Metastasis 28, 39-53.
28. Lee, S.W., Reimer, C.L., Fang, L., Iruela-Arispe, M.L., and Aaronson, S.A. (2000). Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol 20, 1723-1732. (Pubitemid 30100191)
29. Lewis, B.P., Burge, C.B., and Bartel, D.P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20. (Pubitemid 40094598)
30. Martuszewska, D., Ljungberg, B., Johansson, M., Landberg, G., Oslakovic, C., Dahlback, B., et al. (2009). Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer. PLoS One 4, e4350.
31. Michor, F., Iwasa, Y., Lengauer, C., and Nowak, M.A. (2005). Dynamics of colorectal cancer. Semin Cancer Biol 15, 484-493. (Pubitemid 41318048)
32. Milyavsky, M., Tabach, Y., Shats, I., Erez, N., Cohen, Y., Tang, X., et al. (2005). Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res 65, 4530-4543. (Pubitemid 40740788)
33. Min, Y., Ren, X., Vaught, D.B., Chen, J., Donnelly, E., Lynch, C.C., et al. (2010). Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res 70, 2819-2828.
34. Mondello, C., Chiesa, M., Rebuzzini, P., Zongaro, S., Verri, A., Colombo, T., et al. (2003). Karyotype instability and anchorageindependent growth in telomerase-immortalized fibroblasts from two centenarian individuals. Biochem Biophys Res Commun 308, 914-921. (Pubitemid 36976546)
35. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., and Mendell, J.T. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843. (Pubitemid 40839736)
36. Olive, V., Jiang, I., and He, L. (2010). mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42, 1348-1354.
37. Pradervand, S., Weber, J., Thomas, J., Bueno, M., Wirapati, P., Lefort, K., et al. (2009). Impact of normalization on miRNA microarray expression profiling. RNA 15, 493-501.
38. Riou, P., Villalonga, P., and Ridley, A.J. (2010). Rnd proteins: Multifunctional regulators of the cytoskeleton and cell cycle progression. Bioessays 32, 986-992.
39. Roux, S., and Orcel, P. (2000). Bone loss. Factors that regulate osteoclast differentiation: An update. Arthritis Res 2, 451-456. (Pubitemid 32223787)
40. Roy, B.C., Aoyagi, T., Sarkar, S., Nomura, K., Kanda, H., Iwaya, K., et al. (2005). Pathological characterization of Kank in renal cell carcinoma. Exp Mol Pathol 78, 41-48. (Pubitemid 41373315)
41. Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., et al. (2009). p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106, 3207-3212.
42. Saeed, A.I., Bhagabati, N.K., Braisted, J.C., Liang, W., Sharov, V., Howe, E.A., et al. (2006). TM4 microarray software suite. Methods Enzymol 411, 134-193.
43. Schultz, J., Lorenz, P., Gross, G., Ibrahim, S., and Kunz, M. (2008). MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorageindependent growth. Cell Res 18, 549-557. (Pubitemid 351630945)
44. Shi, X., Yang, X., Chen, D., Chang, Z., and Cao, X. (1999). Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J Biol Chem 274, 13711-13717.
45. Smith, H.A., and McNeel, D.G. (2010). The SSX family of cancertestis antigens as target proteins for tumor therapy. Clin Dev Immunol 2010, 150591.
46. Smyth, G.K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article3.
47. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., et al. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genomewide expression profiles. Proc Natl Acad Sci USA 102, 15545-15550. (Pubitemid 41528093)
48. Taberlay, P.C., and Jones, P.A. (2011). DNA methylation and cancer. Prog Drug Res 67, 1-23.
49. Tauber, S., Jais, A., Jeitler, M., Haider, S., Husa, J., Lindroos, J., et al. (2010). Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion. Mol Cancer 9, 200.
50. Trusolino, L., Bertotti, A., and Comoglio, P.M. (2010). MET signalling: Principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11, 834-848.
51. Valastyan, S., and Weinberg, R.A. (2009). MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle 8, 3506-3512.
52. Vie, N., Copois, V., Bascoul-Mollevi, C., Denis, V., Bec, N., Robert, B., et al. (2008). Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Mol Cancer 7, 14.
53. Wang, L., Tang, H., Thayanithy, V., Subramanian, S., Oberg, A.L., Cunningham, J.M., et al. (2009). Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res 69, 9490-9497.
54. Wang, W., Zhang, W., Han, Y., Chen, J., Wang, Y., Zhang, Z., et al. (2005). NELIN, a new F-actin associated protein, stimulates HeLa cell migration and adhesion. Biochem Biophys Res Commun 330, 1127-1131.
55. Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S.R., et al. (2006). Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98, 472-482.
56. Zhu, Y., Kakinuma, N., Wang, Y., and Kiyama, R. (2008). Kank proteins: A new family of ankyrin-repeat domain-containing proteins. Biochim Biophys Acta 1780, 128-133. (Pubitemid 351162892)
57. Zongaro, S., De Stanchina, E., Colombo, T., D'Incalci, M., Giulotto, E., and Mondello, C. (2005). Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line. Cancer Res 65, 11411-11418. (Pubitemid 41821698)